Morgan Stanley Valneva Se Transaction History

Morgan Stanley

$1.36 Trillion
Q1 2025

A detailed history of Morgan Stanley transactions in Valneva Se stock. As of the latest transaction made, Morgan Stanley holds 5,204 shares of VALN stock, worth $32,681. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,204

Previous 2,725 90.97%

Holding current value

$32,681

Previous $11,000 209.09%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$4.31 - $8.33 $10,684 - $20,650	2,479 Added 90.97%	5,204 $34,000
Q4 2024 Feb 14, 2025	SELL	$3.69 - $6.09 $3,066 - $5,060	-831 Reduced 23.37%	2,725 $11,000
Q3 2024 May 14, 2025	BUY	$5.88 - $8.56 $9,272 - $13,499	1,577 Added 79.69%	3,556 $21,000
Q3 2024 Nov 14, 2024	BUY	$5.88 - $8.56 $9,272 - $13,499	1,577 Added 79.69%	3,556 $21,000
Q2 2024 May 14, 2025	SELL	$7.01 - $9.08 $5,229 - $6,773	-746 Reduced 27.38%	1,979 $13,000
Q2 2024 Oct 17, 2024	SELL	$7.01 - $9.08 $24,499 - $31,734	-3,495 Reduced 63.85%	1,979 $13,000
Q2 2024 Aug 14, 2024	SELL	$7.01 - $9.08 $24,499 - $31,734	-3,495 Reduced 63.85%	1,979 $13,000
Q1 2024 Oct 17, 2024	BUY	$6.64 - $10.76 $23,206 - $37,606	3,495 Added 176.6%	5,474 $43,000
Q1 2024 Aug 16, 2024	BUY	$6.64 - $10.76 $7,396 - $11,986	1,114 Added 25.55%	5,474 $43,000
Q1 2024 May 15, 2024	BUY	$6.64 - $10.76 $7,396 - $11,986	1,114 Added 25.55%	5,474 $43,000
Q4 2023 Aug 16, 2024	BUY	$9.88 - $13.82 $23,524 - $32,905	2,381 Added 120.31%	4,360 $45,000
Q4 2023 Feb 13, 2024	BUY	$9.88 - $13.82 $4,940 - $6,910	500 Added 12.95%	4,360 $45,000
Q3 2023 Nov 15, 2023	BUY	$11.36 - $15.85 $5,680 - $7,925	500 Added 14.88%	3,860 $44,000
Q2 2023 Aug 14, 2023	BUY	$9.45 - $16.98 $944 - $1,698	100 Added 3.07%	3,360 $49,000
Q1 2023 May 15, 2023	SELL	$9.98 - $15.89 $17,035 - $27,124	-1,707 Reduced 34.37%	3,260 $33,000
Q4 2022 Feb 14, 2023	SELL	$10.38 - $14.87 $3,072 - $4,401	-296 Reduced 5.62%	4,967 $63,000
Q3 2022 Nov 14, 2022	SELL	$9.8 - $23.35 $29,027 - $69,162	-2,962 Reduced 36.01%	5,263 $53,000
Q2 2022 Oct 27, 2022	SELL	$13.71 - $37.57 $25,980 - $71,195	-1,895 Reduced 18.73%	8,225 $186,000
Q2 2022 Aug 15, 2022	SELL	$13.71 - $37.57 $25,980 - $71,195	-1,895 Reduced 18.73%	8,225 $186,000
Q1 2022 Oct 27, 2022	BUY	$27.0 - $50.99 $51,165 - $96,626	1,895 Added 23.04%	10,120 $347,000
Q1 2022 May 13, 2022	SELL	$27.0 - $50.99 $282,717 - $533,916	-10,471 Reduced 50.85%	10,120 $347,000
Q4 2021 Feb 14, 2022	BUY	$27.1 - $67.28 $474,277 - $1.18 Million	17,501 Added 566.38%	20,591 $1.14 Million
Q3 2021 Nov 15, 2021	BUY	$25.02 - $53.38 $77,311 - $164,944	3,090 New	3,090 $97,000

Others Institutions Holding VALN

# of Institutions

Shares Held

675K

Call Options Held

Put Options Held

View Full List

About Valneva SE

Ticker VALN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,103,504
Market Cap $434M
Description
Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; ...

More about VALN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account